The persistent activation of NRF2 in lung cancer cells is caused by different molecular changes, such as genomic alterations (genetic, epigenetic or oncogene signaling), transcription and translation abnormalities, post-translation modifications and/or altered interactions with other proteins [28,58,74]. This evidence concerns the gene NFE2L2 and lung carcinoma.